- Home
- AKRO vs MEOH Comparison
AKRO vs MEOH Comparison
Compare AKRO & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- MEOH
- Stock Information
- Founded
- AKRO 2017
- MEOH 1968
- Country
- AKRO United States
- MEOH Canada
- Employees
- AKRO N/A
- MEOH N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- MEOH Major Chemicals
- Sector
- AKRO Health Care
- MEOH Industrials
- Exchange
- AKRO Nasdaq
- MEOH Nasdaq
- Market Cap
- AKRO 2.8B
- MEOH 2.5B
- IPO Year
- AKRO 2019
- MEOH N/A
- Fundamental
- Price
- AKRO $37.63
- MEOH $27.02
- Analyst Decision
- AKRO Strong Buy
- MEOH Buy
- Analyst Count
- AKRO 9
- MEOH 8
- Target Price
- AKRO $76.29
- MEOH $49.50
- AVG Volume (30 Days)
- AKRO 1.3M
- MEOH 698.0K
- Earning Date
- AKRO 05-09-2025
- MEOH 04-28-2025
- Dividend Yield
- AKRO N/A
- MEOH 2.74%
- EPS Growth
- AKRO N/A
- MEOH N/A
- EPS
- AKRO N/A
- MEOH 2.39
- Revenue
- AKRO N/A
- MEOH $3,719,829,000.00
- Revenue This Year
- AKRO N/A
- MEOH $17.69
- Revenue Next Year
- AKRO N/A
- MEOH $5.92
- P/E Ratio
- AKRO N/A
- MEOH $11.10
- Revenue Growth
- AKRO N/A
- MEOH N/A
- 52 Week Low
- AKRO $17.86
- MEOH $25.46
- 52 Week High
- AKRO $58.40
- MEOH $56.43
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- MEOH 30.64
- Support Level
- AKRO $36.46
- MEOH $26.47
- Resistance Level
- AKRO $39.13
- MEOH $28.01
- Average True Range (ATR)
- AKRO 3.04
- MEOH 2.00
- MACD
- AKRO 0.06
- MEOH -0.04
- Stochastic Oscillator
- AKRO 57.38
- MEOH 15.84
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.